Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(40%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
4
40%
Ph phase_3
3
30%
Ph early_phase_1
1
10%
Ph not_applicable
2
20%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(8)
Completed(2)

Detailed Status

Not yet recruiting4
Recruiting3
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 33 (30.0%)
Phase 44 (40.0%)
N/A2 (20.0%)

Trials by Status

completed220%
not_yet_recruiting440%
recruiting330%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10